{"id":"W3009982165","doi":"10.1200/jco.2007.25.18_suppl.2554","title":"Pharmacokinetic (PK) interactions between capecitabine (X), oxaliplatin (O) and bevacizumab (A) when used in combination for first-line treatment of metastatic colorectal cancer (MCRC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Capecitabine; Oxaliplatin; Irinotecan; Bevacizumab; Internal medicine; Colorectal cancer; Regimen; FOLFOX; Gastroenterology; Pharmacokinetics; Oncology; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006985352,0.0004379389,0.0008479797,0.0002401721,0.0002544937,0.0006894065,0.0003034952,0.0003410091,0.001233369],"category_scores_gemma":[0.001240711,0.0003877246,0.0004565019,0.0002626963,0.0004985397,0.0005136998,0.0002137711,0.001015658,0.0002071244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009064629,"about_ca_system_score_gemma":0.0006356334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000921018,"about_ca_topic_score_gemma":0.0016475,"domain_scores_codex":[0.9995017,0.0002533616,0.00002120278,0.00006826898,0.00009932964,0.00005605075],"domain_scores_gemma":[0.9996145,0.0001262047,0.0001754642,0.00001946295,0.00001286049,0.00005159027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.09884632,0.0133565,0.04389825,0.0007160071,0.001188132,0.0009446851,0.0004591071,0.01941297,0.6599739,0.0002976578,0.002949357,0.1579571],"study_design_scores_gemma":[0.02371278,0.4166251,0.2293236,0.0000790084,0.001926974,0.008738386,0.0003107292,0.04682339,0.2535912,0.000727051,0.01795545,0.000186246],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971178,0.001268481,0.0007157029,0.00007166505,0.00001493394,0.0001234652,0.0001427521,0.00003311031,0.0005120855],"genre_scores_gemma":[0.9980593,0.0005181333,0.0007665133,0.00004917726,0.00003475537,0.00008401151,0.0001740324,0.000008696318,0.0003054157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001233369,"threshold_uncertainty_score":0.006576896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2125737846274122,"score_gpt":0.5383188680677896,"score_spread":0.3257450834403774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}